# Carcinoma, Transitional Cell studies recruiting: 37 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials that are observational for Carcinoma, Transitional Cell that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Carcinoma, Transitional Cell studies: 37 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/carcinoma-transitional-cell

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 37
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888374 | Urinary Cell-Free DNA Liquid Biopsy for Urothelial Cancer Diagnosis and Origin Identification | Ruijin Hospital | Observational | Recruiting | Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma, Bladder Cancer | 477 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888374) |
| October 2, 2026 | NCT07855926 | Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS) | LMU Klinikum | Observational | Recruiting | Urothelial Carcinoma of the Bladder, Muscle Invasive Bladder Cancer (MIBC) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855926) |
| August 27, 2026 | NCT07789119 | Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related... | M.D. Anderson Cancer Center | Observational | Recruiting | Urothelial Carcinoma | 50,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789119) |
| August 10, 2026 | NCT07756437 | Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Muscle-Invasive Bladder Cancer (MIBC), Upper Tract Urothelial Carcinoma, Urothelial Carcinoma (UC) | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07756437) |
| August 4, 2026 | NCT07744958 | RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer) | Heinrich-Heine University, Duesseldorf | Observational | Not yet recruiting | Muscle Invasive Bladder Cancer (MIBC) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07744958) |
| June 29, 2026 | NCT07673016 | Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer | Convergent Genomics, Inc. | Observational | Recruiting | Bladder Cancer, Urothelial Carcinoma (UC), Hematuria, Upper Tract Urothelial Cancer | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673016) |
| May 29, 2026 | NCT07614594 | Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis | Henan Provincial People's Hospital | Observational | Recruiting | Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma, UTUC, Bladder Cancer (BC) | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614594) |
| May 22, 2026 | NCT07602010 | Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging | Oslo University Hospital | Observational | Recruiting | Bladder Cancer, Urothelial Carcinoma (UC), Muscle Invasive Bladder Cancer (MIBC), Non Muscle Invasive Bladder Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602010) |
| May 15, 2026 | NCT07589413 | Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT | Sponsor not shown (see the record) | Observational | Recruiting | Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Recurrence, Progression of Bladder Cancer, Transurethral... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589413) |
| April 13, 2026 | NCT07525349 | Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer | Assiut University | Observational | Not yet recruiting | Muscle-Invasive Bladder Carcinoma, Urothelial Carcinoma (UC), Bladder Cancer, Muscle-Invasive Urothelial Bladder... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07525349) |
| March 20, 2026 | NCT07485114 | Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung... | Sponsor not shown (see the record) | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Transitional Cell Carcinoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485114) |
| March 5, 2026 | NCT07452432 | Korean Prospective Upper Tract Urothelial Carcinoma Cohort | Samsung Medical Center | Observational | Recruiting | Urothelial Carcinoma (UC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07452432) |
| March 2, 2026 | NCT07441499 | Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma | Tianjin Medical University Second Hospital | Observational | Recruiting | Urothelial Carcinoma (UC), Bladder (Urothelial, Transitional Cell) Cancer, Liquid Biopsy | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07441499) |
| February 9, 2026 | NCT07395037 | A Study of Ward Admissions for Haematuria | British Urology Researchers in Surgical Training | Observational | Recruiting | Urologic Diseases, Hematuria, Hematuria; Benign, Bladder Cancer, Renal Cancer, Urothelial Carcinoma | 1,050 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07395037) |
| February 5, 2026 | NCT07390617 | A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma | Memorial Sloan Kettering Cancer Center | Observational | Recruiting | Neuropathy, Urothelial Carcinoma, Metastatic Urothelial Carcinoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390617) |
| January 14, 2026 | NCT07339878 | Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma | University Hospital, Strasbourg, France | Observational | Recruiting | Metastatic Urothelial Carcinoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07339878) |
| January 12, 2026 | NCT07334314 | Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs | University Hospital, Strasbourg, France | Observational | Recruiting | Urothelial Carcinoma | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07334314) |
| July 18, 2025 | NCT07072637 | Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy | National Taiwan University Hospital | Observational | Not yet recruiting | Locally Advanced or Metastatic Urothelial Carcinoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07072637) |
| June 25, 2025 | NCT07037589 | Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? | Vastra Gotaland Region | Observational | Recruiting | Hematuria, Acute Cystitis With Hematuria, Bladder Cancer, Urothelial Carcinoma, Renal Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07037589) |
| May 21, 2025 | NCT06982794 | A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma | IRCCS San Raffaele | Observational | Recruiting | Urothelial Carcinoma (UC) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06982794) |
| April 6, 2025 | NCT06912672 | Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma | Shanghai Epiprobe Biotechnology Co., Ltd. | Observational | Not yet recruiting | Urothelial Carcinoma | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06912672) |
| December 9, 2024 | NCT06724159 | Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors. | Spanish Oncology Genito-Urinary Group | Observational | Recruiting | Genitourinary Cancers | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06724159) |
| October 24, 2024 | NCT06657157 | Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced... | Comprehensive Cancer Center Munich (CCCM) | Observational | Recruiting | Urothelial Cancer | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06657157) |
| June 21, 2024 | NCT06469229 | Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria | Changhai Hospital | Observational | Not yet recruiting | Hematuria, Urothelial Carcinoma, Bladder Cancer, Ureter Cancer, Renal Pelvis Cancer | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06469229) |
| May 2, 2024 | NCT06396533 | Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) | Fox Chase Cancer Center | Observational | Recruiting | Urothelial Carcinoma, Muscle Invasive Bladder Urothelial Carcinoma, Non-Muscle Invasive Bladder Urothelial Carcinoma | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06396533) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| IRCCS San Raffaele | 2 |
| University Hospital, Strasbourg, France | 2 |
| National Taiwan University Hospital | 2 |
| Spanish Oncology Genito-Urinary Group | 1 |
| British Urology Researchers in Surgical Training | 1 |
| Convergent Genomics, Inc. | 1 |
| LMU Klinikum | 1 |
| Ruijin Hospital | 1 |
| Oslo University Hospital | 1 |
| Henan Provincial People's Hospital | 1 |
| Shanghai Epiprobe Biotechnology Co., Ltd. | 1 |
| Tampere University Hospital | 1 |
| Samsung Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
| Tianjin Medical University Second Hospital | 1 |
| University Hospital, Toulouse | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
| Vastra Gotaland Region | 1 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 1 |
| Massive Bio, Inc. | 1 |
| Cofactor Genomics, Inc. | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Comprehensive Cancer Center Munich (CCCM) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 9 |
| China | 6 |
| Germany | 4 |
| Italy | 3 |
| France | 3 |
| Puerto Rico | 2 |
| Taiwan | 2 |
| Spain | 1 |
| United Kingdom | 1 |
| Norway | 1 |
| Israel | 1 |
| Canada | 1 |
| Finland | 1 |
| Japan | 1 |
| South Korea | 1 |
| Belgium | 1 |
| Sweden | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Debt relief companies in the United States](https://specstream.ai/data/businesses/debt-relief-companies/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
- [B2B transportation and storage companies in the United States](https://specstream.ai/data/businesses/b2b-transportation-and-storage-companies/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [Urology practices in the United States](https://specstream.ai/data/businesses/urology-practices/united-states)
- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
